<qa>  What is the name of the study that is being approved by the Food and Drug Administration?This is an investigational study. The Food and Drug Administration FDA has approved palonosetron and Ondansetron for the prevention of chemotherapy-related nausea and vomiting, and both drugs are commercially available. Up to 150 participants will take part in this study. All will be enrolled at UT MD Anderson Cancer Center. 